Photo by Miodrag Ignjatovic/Getty Images
Over the last decade, marijuana has been legalized for recreational use in more than 20 states. From chocolates to tinctures, marijuana products have become mainstream, and its culture is expanding. For some, marijuana’s psychoactive properties, stimulated by the delta-9-tetrahydrocannabinol (THC) compound in the cannabis plant, is not something they want. Instead, they look into another compound that has received attention for its extensive anecdotal reports of helping ease anxious minds, assisting better sleep, relieving pain, mitigating cravings, and even decreasing seizures in pediatric patients. That compound is CBD.
CBD, short for cannabidiol, is “the second most prevalent active ingredient in cannabis (marijuana),” according to Harvard Health, but does not feature the psychoactive properties of THC. There is a lack of research on how CBD can benefit or harm breastfeeding mothers and their infants. The effects of CBD on nursing mothers and their babies still lacks conclusions.
The FDA’s Rules and Regulations
Photo by Chokniti-Studio/Shutterstock
The US Food and Drug Administration (FDA) has many regulations when it comes to cannabis, some of which have previously made researching CBD for its potential benefits difficult. The Drug Enforcement Administration (DEA) made the process easier in 2015 when it allowed researchers to obtain the CBD they needed for continued studies. However, research is still stunted. Although CBD derived from hemp is legal at the federal level, regulatory caveats can change state-by-state, and at the time of writing
0 Comments